Skip to main content
APRE logo

APRE

Aprea Therapeutics, Inc.
$0.74 0.00 (-0.54%) At close · Jul 2
Market Cap
$9.18M
Shares
12,382,776

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 22
Total Value: $1,712,397
Total Shares: 2,244,310

Institutional Ownership Trend

13 quarters

Holder Concentration

Across 22 13F filers · Δ vs Dec 31, 2025
Top Holder
45.2%
Jun 2023 → Mar 2026 · range 21.9% – 45.2%
+23.4 pts
Top 5
87.4%
Jun 2023 → Mar 2026 · range 68.6% – 92.7%
+10.3 pts
Top 10
95.6%
Jun 2023 → Mar 2026 · range 92.9% – 99.5%
+2.4 pts
HHI
2,566
Jun 2023 → Mar 2026 · range 1,323 – 2,566
Highly concentrated+1,172

Quarterly Activity

vs Dec 31, 2025
New
7
Increased
4
Decreased
5
Sold Out
7
Unchanged
6
Holder count: 0
Institutional value: +18.4%
Shares held: +32.4%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 22 of 22
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1781983 CUSIP 03836J201 Visit website Investor relations